New dementia drugs too costly, says clinician
The cost of a new wave of drugs to treat Alzheimer’s disease may be too prohibitive for many people living...
alzheimers
Twin study offers hope for Alzheimer’s disease
A recent study revealed that one of the hallmark features of Alzheimer’s disease is only partially connected to genes. The...
Expert group investigates link between COVID and dementia
International dementia experts have formed a consortium to study the link between covid-19 and dementia, amid growing evidence the virus...
Alzheimer’s drug trial shows promise
Rosie Craven enjoying reading her latest book Participants in an international trial investigating a drug to slow down cognitive decline...
ADNet head discusses vision for future of dementia
A new dementia initiative aims to cut recruitment time for trials from the current waiting period of three years to...